Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Westermark

Showing results (11-20 of 130) with videos related to

Pageof 13
Sort By:
Experimental Diabetes Research|October 1, 2008
Transthyretin and amyloid in the islets of Langerhans in type-2 diabetesGunilla T Westermark, Per Westermark
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Review. Reflections on amyloidosis in Papua New GuineaPer Westermark, Gunilla T Westermark
Methods in Molecular Biology (Clifton, N.J.)|June 28, 2005
Purification of amyloid protein AA subspecies from amyloid-rich human tissuesGunilla T Westermark, Per Westermark
The Science of the Total Environment|February 1, 1989
Can zeolites decrease the uptake and accelerate the excretion of radio-caesium in ruminants?S Forberg, B Jones, T Westermark
Diabetes|June 29, 2005
Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formationJohan F Paulsson, Gunilla T Westermark
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2012
AA-Amyloid is cleared by endogenous immunological mechanismsSofia N Nyström, Gunilla T Westermark
Current Diabetes Reports|June 3, 2005
Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?Per Westermark, Arne Andersson, Gunilla T Westermark
Annual Review of Pathology|November 12, 2014
AA amyloidosis: pathogenesis and targeted therapyGunilla T Westermark, Marcus Fändrich, Per Westermark
Physiological Reviews|July 12, 2011
Islet amyloid polypeptide, islet amyloid, and diabetes mellitusPer Westermark, Arne Andersson, Gunilla T Westermark
Scandinavian Journal of Immunology|November 13, 2009
Alkali-degradation of amyloid: an ancient method useful for making monoclonal antibodies against amyloid fibril proteinsG T Westermark, K Sletten, P Westermark
Pageof 13

Showing results (11-20 of 130) with videos related to

Sort By:
Pageof 13
Experimental Diabetes Research|October 1, 2008
Transthyretin and amyloid in the islets of Langerhans in type-2 diabetesGunilla T Westermark, Per Westermark
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|October 14, 2008
Review. Reflections on amyloidosis in Papua New GuineaPer Westermark, Gunilla T Westermark
Methods in Molecular Biology (Clifton, N.J.)|June 28, 2005
Purification of amyloid protein AA subspecies from amyloid-rich human tissuesGunilla T Westermark, Per Westermark
The Science of the Total Environment|February 1, 1989
Can zeolites decrease the uptake and accelerate the excretion of radio-caesium in ruminants?S Forberg, B Jones, T Westermark
Diabetes|June 29, 2005
Aberrant processing of human proislet amyloid polypeptide results in increased amyloid formationJohan F Paulsson, Gunilla T Westermark
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|August 21, 2012
AA-Amyloid is cleared by endogenous immunological mechanismsSofia N Nyström, Gunilla T Westermark
Current Diabetes Reports|June 3, 2005
Is aggregated IAPP a cause of beta-cell failure in transplanted human pancreatic islets?Per Westermark, Arne Andersson, Gunilla T Westermark
Annual Review of Pathology|November 12, 2014
AA amyloidosis: pathogenesis and targeted therapyGunilla T Westermark, Marcus Fändrich, Per Westermark
Physiological Reviews|July 12, 2011
Islet amyloid polypeptide, islet amyloid, and diabetes mellitusPer Westermark, Arne Andersson, Gunilla T Westermark
Scandinavian Journal of Immunology|November 13, 2009
Alkali-degradation of amyloid: an ancient method useful for making monoclonal antibodies against amyloid fibril proteinsG T Westermark, K Sletten, P Westermark
Pageof 13